The Swiss orthobiologics company Kuros Biosciences Ltd has promoted Philippe Saudan to the position of chief development officer and member of the executive board. He was previously head of integration, overseeing programmes in tissue repair and regeneration.
Before joining Kuros, Dr Saudan was chief scientific officer at Cytos Biotechnology Ltd, a vaccine company. Cytos entered into a reverse merger with Kuros in late 2015 to create a new Switzerland-based company controlled by Kuros’ shareholders.
Kuros announced the appointment on 10 August 2016.
Copyright 2016 Evernow Publishing Ltd